Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isobiotic HPy3
- Development stage
- Unknown
- Lead developer
- ISOMED PHARMA
- Modality
- Small Molecules, Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Isobiotic HPy3 is an oral probiotic supplement developed by ISOMED PHARMA, specifically formulated as an adjunctive treatment to support the eradication of *Helicobacter pylori* infection. It contains a combination of selected probiotic strains and phytotherapeutic extracts that work synergistically to modulate the gut microbiota rather than exerting direct antimicrobial targeting against the pathogen. By supporting gut health and microbial balance during conventional antibiotic therapy, Isobiotic HPy3 aims to improve the success rate of eradication regimens and potentially mitigate common gastrointestinal side effects associated with intensive antibiotic use. The product is marketed as a dietary supplement and is recommended for use alongside standard medical treatments, typically with a two-hour separation from antibiotic doses.
- Brand names
- Isobiotic HPy3
- Other names
- Isobiotic HPy 3
Beyond the preview
Go deeper on Isobiotic HPy3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Isobiotic HPy3.